IAN Fund
301-302, 3rd floor, Delhi Blue Apartments, Main Ring Road, Near Safdarjung Hospital, New Delhi, Delhi, 110029, India
Overview
IAN FUND is a unique early stage fund. Over the years, IAN has become a revolution in the angel investment space. The logical next step was to create country’s largest horizontal platform for seed/early stage investments. With a customer & enterprise focus, leveraging India’s technology strengths & growing consumer markets the focus is now to turn around Long term commitment on seed / early stage.
- Total investments
- 35
- Lead investments
- 18
- Investments · 12mo
- 7
- Active investors
- 6
Investment portfolio
- Invisel
Led · Equity · Aug 2026
Invisel develops and sells invisible nano coatings that form a protective layer on surfaces such as glass, marble, tiles, fabric, leather and metal, with a single application lasting between 6–12 months and taking minutes to apply. The company sells direct-to-consumer, works with institutional OEM partners in the furniture industry, and offers professional application services across multiple cities. Within just over a year of commercial operations it has served more than 60,000 customers across 900+ pin codes, generated ₹5.2 crore in FY26 revenue, and achieved profitability without prior external funding. Founded by Atharva Ulangwar (Founder & CEO) and Sumedh Yeolekar (Co-founder & CMO), Invisel has built in-house formulation and manufacturing capabilities and plans to establish a dedicated manufacturing and research facility in Pune. Future plans include expanding its professional application network from three to twelve cities, launching in the UAE later this year, introducing five new product categories, and investing in advanced materials research and patent development.
- Biodimension
Led · Equity · Jun 2026
Biodimension develops biofabricated human tissue and organoid models and offers a portfolio including BioDEpi, BioDFT, BioDPigma, a Pan-Cancer Tumour Microenvironment Biobank, and a Bioassay-as-a-Service (BaaS) platform for research, safety assessment, and drug discovery. The company works with pharmaceutical firms, biotech companies, research institutions, and contract research organizations, and has collaborations across India and Singapore. Biodimension plans to expand its oncology research offerings, scale its BaaS platform, and enter additional international markets such as Southeast Asia. The recent Rs 8 crore funding led by IAN Angel Fund will be used to accelerate product development, expand lab infrastructure, and strengthen scientific and commercial teams to support commercialization domestically and overseas. The company was founded by Manojkumar S., Ranjith Kumar Velusamy, and Pradeep Arunachalam and is based in Bengaluru.
- The Sweet Change
Led · Equity · May 2026
Founded in 2024 by Manvi Agnihotri and Sheen Hitashi, The Sweet Change offers natural sweeteners positioned as zero calorie, zero sugar, and zero glycemic index alternatives to refined sugar. The company targets health-conscious consumers and people managing medical or lifestyle conditions that require controlled sugar intake. It has crossed Rs 1.5 crore in revenue and fulfilled more than 12,000 orders through its own website. Current go-to-market channels include direct-to-consumer sales, marketplaces, and quick-commerce platforms, with plans to expand presence across those channels. The startup is also evaluating entry into cafes, the hospitality sector, and institutional partnerships as it scales. Recent funding will be used to support product development, team building, and expanded distribution and marketing efforts across India.
- Peping
Led · Equity · Mar 2026
Peping develops shelf-stable functional beverages, offering a dual product line of flavoured prebiotic fizzy sodas for everyday refreshment and concentrated probiotic shots for targeted digestive support. By positioning itself between niche kombucha labels and clinical probiotic capsules, the company seeks to provide great-tasting, affordable options for mass-market Indian consumers. Its drinks are currently available on Swiggy Instamart, Zepto, BigBasket, First Club, Namdhari’s, Ratnadeep, and more than 200 brick-and-mortar outlets across Bengaluru, as well as in gyms, cafés, and corporate offices via catering partnerships. Peping has built its own production facility from off-the-shelf components and brought canning in-house to lift margins and improve quality control. With fresh capital, the founders plan to widen distribution, reinforce supply-chain capabilities, invest in brand building, and roll out additional flavours. Founded by brothers Chirag and Prateek Maheshwari, the startup recently secured Rs 2.5 crore to accelerate these initiatives.
- EndureAir Systems
Participated · Equity · Oct 2025
Founded in 2018 within the IIT Kanpur ecosystem, EndureAir Systems has evolved from a research-driven initiative into a developer of mission-ready unmanned aerial platforms designed and manufactured in-house. The company's flagship program, the SABAL-200, is a VTOL unmanned aerial system engineered to carry up to 200 kg with an endurance of 2.5 hours and a range of 200 kilometres, and incorporates a variable-pitch rotor, a turbocharged internal combustion engine and an advanced mechanical powertrain. EndureAir's UAV portfolio builds on more than a decade of rotorcraft R&D and earlier platforms, including the SABAL-20 and SABAL-40, which have been deployed across defence and civilian applications in high-altitude and challenging terrain. The recent ₹30.01 crore RDI funding is intended to accelerate the SABAL-200 from TRL 5 to TRL 9 and to expand manufacturing, testing and field-deployment capabilities. The company plans to strengthen indigenous engineering and design capabilities, scale production and operations, and support aerial logistics for defence and civilian infrastructure in remote regions. As it scales, EndureAir expects the program to generate employment opportunities across Tier 2 and Tier 3 cities.